Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanomaElin S. Gray, Mel Ziman|Oncotarget|2015Cited by 327
Tumour PD-L1 Expression in Small-Cell Lung Cancer: A Systematic Review and Meta-AnalysisEmmanuel Acheampong, Elin S. Gray|Cells|2020Cited by 72
Is the Blood an Alternative for Programmed Cell Death Ligand 1 Assessment in Non-Small Cell Lung Cancer?Emmanuel Acheampong, Elin S. Gray|Cancers|2019Cited by 12
Abstract B044: Fragmentomic features of cell-free DNA predict late-stage melanoma treatment benefit and survivalAaron B. Beasley, Elin S. Gray, Leslie Calapre et al.|Clinical Cancer Research|2024Cited by 0
Pre-Amplification of Cell-Free DNA: Balancing Amplification Errors with Enhanced SensitivityWei Yen Chan, Helen Rizos, Jenny Lee et al.|Biomolecules|2025Cited by 0